Search research articles
Contact Us
Filters
Showing results (81-90 of 137) with videos related to
Page
of 14
Sort By:
Blood Advances
|
June 23, 2023
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
Betty K Hamilton, Lisa A Rybicki, Hong Li, et al.
Leukemia
|
July 22, 2022
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis
Ruben Mesa, Claire Harrison, Stephen T Oh, et al.
Bone Marrow Transplantation
|
October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation
Sagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Leukemia & Lymphoma
|
March 7, 2022
Momelotinib reduces transfusion requirements in patients with myelofibrosis
Ruben Mesa, Stephen T Oh, Aaron T Gerds, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 7, 2017
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience
Yazeed Sawalha, Brian T Hill, Lisa A Rybicki, et al.
Blood Advances
|
November 2, 2022
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia
Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Leukemia & Lymphoma
|
April 9, 2025
Impact of <i>TP53</i> mutation on survival outcomes in acute lymphoblastic leukemia at a tertiary center
Meera Patel, Emily C Zabor, Ahmed Mohamed, et al.
JAMA Oncology
|
March 10, 2018
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial
John Mascarenhas, Ronald Hoffman, Moshe Talpaz, et al.
Blood Advances
|
May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Blood Advances
|
September 11, 2020
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial
Stephen T Oh, Moshe Talpaz, Aaron T Gerds, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 137) with videos related to
Sort By:
Page
of 14
Blood Advances
|
June 23, 2023
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
Betty K Hamilton, Lisa A Rybicki, Hong Li, et al.
Leukemia
|
July 22, 2022
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis
Ruben Mesa, Claire Harrison, Stephen T Oh, et al.
Bone Marrow Transplantation
|
October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation
Sagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Leukemia & Lymphoma
|
March 7, 2022
Momelotinib reduces transfusion requirements in patients with myelofibrosis
Ruben Mesa, Stephen T Oh, Aaron T Gerds, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 7, 2017
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience
Yazeed Sawalha, Brian T Hill, Lisa A Rybicki, et al.
Blood Advances
|
November 2, 2022
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia
Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Leukemia & Lymphoma
|
April 9, 2025
Impact of <i>TP53</i> mutation on survival outcomes in acute lymphoblastic leukemia at a tertiary center
Meera Patel, Emily C Zabor, Ahmed Mohamed, et al.
JAMA Oncology
|
March 10, 2018
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial
John Mascarenhas, Ronald Hoffman, Moshe Talpaz, et al.
Blood Advances
|
May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Blood Advances
|
September 11, 2020
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial
Stephen T Oh, Moshe Talpaz, Aaron T Gerds, et al.
Page
of 14